American Academy of Ophthalmology Meeting

American Academy of Ophthalmology Meeting

November 12, 2021
1 min watch
Save

VIDEO: Opus Genetics plans to bring therapies for rare retinal diseases to clinical trials

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

NEW ORLEANS — In this Healio Video Perspective from the Eyecelerator meeting, Ben Yerxa, PhD, acting CEO of Opus Genetics, discusses the company’s plans, including the beginning of trials of OPGx-001, designed to target the LCA5 gene.